医学
氮质血症
急性肾损伤
肾
纤维化
透析
肾脏疾病
重症监护医学
肾病科
炎症
内科学
肾功能
出处
期刊:Critical Care
[BioMed Central]
日期:2022-04-28
卷期号:26 (1): 116-116
被引量:12
标识
DOI:10.1186/s13054-022-03988-0
摘要
Preclinical models of acute kidney injury (AKI) consistently demonstrate that a uremic milieu enhances renal recovery and decreases kidney fibrosis. Similarly, significant decreases in monocyte/macrophage infiltration, complement levels, and other markers of inflammation in the injured kidney are observed across multiple studies and species. In essence, decreased renal clearance has the surprising and counterintuitive effect of being an effective treatment for AKI. In this Perspective, the author suggests a hypothesis describing why the uremic milieu is kidney protective and proposes a clinical trial of 'permissive azotemia' to improve renal recovery and long-term renal outcomes in critically ill patients with severe AKI.
科研通智能强力驱动
Strongly Powered by AbleSci AI